BioAdaptives Financials
| BDPT Stock | USD 0.04 0.01 19.77% |
BioAdaptives |
Understanding current and past BioAdaptives Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioAdaptives' financial statements are interrelated, with each one affecting the others. For example, an increase in BioAdaptives' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in BioAdaptives' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioAdaptives. Check BioAdaptives' Beneish M Score to see the likelihood of BioAdaptives' management manipulating its earnings.
BioAdaptives Stock Summary
BioAdaptives competes with Bit Origin. BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 3 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US09072U1079 |
| Business Address | 2620 Regatta Drive, |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Benchmark | Dow Jones Industrial |
| Website | www.shopbioadaptives.com |
| Phone | 702 659 8829 |
| Currency | USD - US Dollar |
BioAdaptives Key Financial Ratios
BioAdaptives' financial ratios allow both analysts and investors to convert raw data from BioAdaptives' financial statements into concise, actionable information that can be used to evaluate the performance of BioAdaptives over time and compare it to other companies across industries.| Return On Asset | -3.43 | |||
| Beta | -0.29 | |||
| Z Score | -41.0 |
BioAdaptives Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioAdaptives's current stock value. Our valuation model uses many indicators to compare BioAdaptives value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioAdaptives competition to find correlations between indicators driving BioAdaptives's intrinsic value. More Info.BioAdaptives is rated below average in return on asset category among its peers. It is rated fifth in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioAdaptives' earnings, one of the primary drivers of an investment's value.BioAdaptives Systematic Risk
BioAdaptives' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioAdaptives volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on BioAdaptives correlated with the market. If Beta is less than 0 BioAdaptives generally moves in the opposite direction as compared to the market. If BioAdaptives Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioAdaptives is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioAdaptives is generally in the same direction as the market. If Beta > 1 BioAdaptives moves generally in the same direction as, but more than the movement of the benchmark.
BioAdaptives Thematic Clasifications
BioAdaptives is part of Penny investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Strong penny or near-penny equities. Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2
This theme covers Strong penny or near-penny equities. Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. Get More Thematic Ideas
| Penny | View |
BioAdaptives July 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioAdaptives help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioAdaptives. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioAdaptives based on widely used predictive technical indicators. In general, we focus on analyzing BioAdaptives Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioAdaptives's daily price indicators and compare them against related drivers.
| Downside Deviation | 18.4 | |||
| Information Ratio | 2.0E-4 | |||
| Maximum Drawdown | 74.59 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 32.85 |
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.